You are viewing an incomplete version of our website. Please click to reload the website as full version.

YB-1 antibodies: antibodies-online obtains exclusive license from Aachen University Hospital

antibodies-online and Aachen University Hospital (UKA) signed an exclusive license agreement for monoclonal YB-1 antibodies developed by a research group at UKA.
YB-1 is an ancient member of the coldshock domain. It has been shown that YB-1 plays a role in numerous cancer diseases as well as cardiovascular disease.

YB-1 antibodies at antibodies-online: